40751 - Lymphoma Rounds and Panel Discussion: Frontline Decision-Making for Aggressive Lymphoma

The Lymphoma Rounds Symposium program provides a forum for practicing physicians from academic and community medical centers to meet throughout the academic year and address issues specific to the diagnosis and treatment of their lymphoma patients. In this program, physicians can network, share best practices, and learn the latest information on new therapies and advances in lymphoma management through interactive case studies presented by lymphoma experts.

This activity reviews management of limited-stage aggressive B-cell lymphoma, including response-adapted strategies based on level of disease risk. In the panel discussion that follows, clinicians from a variety of practice settings discuss how they are integrating emerging circulating tumor DNA assays to complement end-of-therapy management.

There are no fees to participate in the activity. Participants must review all activity information, including the learning objectives, disclosure statements, and content. To receive CME credit for participation, participants must complete the posttest and program evaluation. Certificates can be printed immediately.

1. Summarize the latest developments in lymphoma diagnosis, treatment and management
2. Apply best practices for treating lymphoma patients
3. Inform patients about potential clinical trial opportunities
4. Establish a network of health care professionals who work with lymphoma patients

The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

COI / Disclosure of Relationships with Ineligible Entities

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the University of Cincinnati policy, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies* (commercial interests) within the last 24 months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify from involvement in the planning and implementation of accredited continuing education any individuals (1) who refuse to provide this information or (2) whose conflicts of interests cannot be mitigated.

*Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant relationships have been mitigated. The following disclosures were made:

The University of Cincinnati, Lymphoma Research Foundation, and RedMedEd faculty and staff involved in the development and review of this activity have disclosed no relevant financial relationships.

Disclosure of Unlabeled Use

The faculty of this educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. The University of Cincinnati, the Lymphoma Research Foundation, and RedMedEd do not recommend the use of any agent outside the labeled indications may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturers product labeling.

Disclaimer Statement

The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati, the Lymphoma Research Foundation, and RedMedEd.